Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Lipscombe LL. Exenatide did not reduce major cardiovascular outcomes in type 2 diabetes. Ann Intern Med 2017;167:JC67.
PMID: 29255857


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016